Iridex to Report First Quarter 2021 Financial Results on May 11, 2021
MOUNTAIN VIEW, Calif., April 27, 2021 (GLOBE NEWSWIRE) Iridex Corporation (NASDAQ: IRIX), a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and retinal diseases, today announced the Company will release financial results for the first quarter of 2021 after the close of trading on Tuesday, May 11, 2021. The Company’s management team will host a corresponding conference call beginning at 2:00 p.m. PT / 5:00 p.m. ET.
Investors interested in listening to the conference call may do so by dialing (844) 707-0665 for domestic callers or (703) 326-3030 for international callers, using conference ID: 1282162. A live and archived webcast of the event will be available on the “Investors” section of the Company’s website at: www.iridex.com.
AsclepiX Therapeutics, Inc Appoints Robert J Dempsey as Chief Executive Officer and President
pittsburghstar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pittsburghstar.com Daily Mail and Mail on Sunday newspapers.
AsclepiX Therapeutics, Inc Appoints Robert J Dempsey as Chief Executive Officer and President
phoenixherald.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from phoenixherald.com Daily Mail and Mail on Sunday newspapers.